News & Updates

New drug applications approved by US FDA as of 16 - 30 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Wearing filtering facepiece 3 (FFP3) masks for more than the recommended 1-hour duration can lead to facial injuries, a new study has found.

The C5 and leukotriene B4 inhibitor nomacopan helps suppress acute flares in older patients with bullous pemphigoid, according to the results of a phase IIa study.

A compact device that incorporates high-resolution millimetre-wave imaging (HR-MMWI) can diagnose malignant skin lesions as accurately as clinical examination and other detection techniques, potentially cutting the number of unnecessary biopsies in half, as reported in a study.

Epigallocatechin-3-gallate, a catechin that is most potent and abundant in tea, is a potential skin care solution in patients receiving radiotherapy, with a phase II study showing that it helps reduce the incidence and severity of radiation-induced dermatitis.

Adjuvant radiation (ART) after a clear margin surgery reduces the risk of local recurrence and locoregional recurrence in patients with high T-stage cutaneous squamous cell carcinomas, reports a recent study.

Pretreatment with oral cholecalciferol (vitamin D3) results in significant improvements in clinical responses of actinic keratoses (AKs) to blue light photodynamic therapy (PDT), reports a study. In addition, the regimen is well tolerated by patients.